Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.00 -0.07 (-2.40%)
As of: Oct 21, 2026 · 1:18 PM EDT

Galmed Pharmaceuticals (EOCN) EBITDA Margin (2016 - 2023)

Updated

Galmed Pharmaceuticals (EOCN) posted EBITDA Margin of 544.75% for FY2018, down 616.82 percentage points from 1161.57% in FY2017.

Analysis

Galmed Pharmaceuticals (EOCN) EBITDA Margin (2016 - 2023) Analysis & Trends

  • Business Quant data shows EOCN's EBITDA Margin at 1161.57% in FY2017 (-2489.61 pp) and 3651.18% in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,134.13 Bn 1,102.72 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn 35.95%
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn 49.01%
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 6.02%
5 Novartis Ag 297.88 Bn 261.87 Bn 11.24 Bn -
6 Astrazeneca 261.36 Bn 235.05 Bn 12.86 Bn 33.11%
7 Amgen 235.80 Bn 191.20 Bn 7.24 Bn 46.01%
8 Gilead Sciences 190.78 Bn 164.97 Bn 6.22 Bn -124.26%
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn 39.16%
10 Galmed Pharmaceuticals 1.61 Mn -39.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -285.00%
Mar 31, 2022 -233.33%
Sep 30, 2018 83.07%
Jun 30, 2018 -977.41%
Mar 31, 2018 980.22%
Dec 31, 2017 -7,597.45%
Sep 30, 2017 1,038.46%
Jun 30, 2017 -999.63%
Mar 31, 2017 1,188.06%
Dec 31, 2016 1,762.77%
Sep 30, 2016 1,989.64%
API Access

Galmed Pharmaceuticals EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EOCN&period=max&api_key=YOUR_API_KEY